Analysts/Institutional Investor Meet/Con. Call Updates

July 23, 2026 To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS Dear Sirs, Enclosed please find herewith the details of Earnings Call slated for Friday, July 31, 2026 from 8:30 a.m. to 9:30 a.m. (IST), for your information and record. Thanking you Yours faithfully, For Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Rudalf Corriea Company Secretary & Compliance Officer Encl.: As above Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Corporate Office: Registered Office: Technopolis Knowledge Park, A wing, Office No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate 4th Floor, Mahakali Caves Road, Andheri ( E), Mumbai – 400093 Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com I N V I T A T I O N Alivus Life Sciences Ltd. (Formerly Glenmark Life Sciences Ltd.) Q1 FY2026-27 Financial Performance - Earnings Call Date: Friday, July 31, 2026 Time: 8:30 am – 9:30 am [IST] Universal Dial-in Numbers: +91 22 6280 1564 +91 22 7115 8394 International Toll Free: Australia 1800053698 Canada 01180014243444 China 4008428405 Hong Kong 800964448 Italy 0080014243444 Japan 00531161110 Singapore 8001012045 South Korea 00180014243444 UK 08081011573 USA 18667462133 International Toll: HongKong +852 30186877 Japan +81 345899421 Singapore +65 31575746 SouthAfrica +27 110623033 UK +44 2034785524 USA +1 3233868721 To pre-register online, please click here For any clarification, please contact: Diwakar Pingle E-mail: Diwakar.Pingle@in.ey.com Runjhun Jain E-mail: Runjhun.Jain1@in.ey.com Phone: [+91 9820720993]